The largest database of trusted experimental protocols

Cellgro

Manufactured by CellGenix
Sourced in Germany

CellGro is a cell culture media product line developed by CellGenix. It provides a variety of formulations optimized for the growth and maintenance of different cell types, including various primary cells and cell lines. CellGro media are designed to support cell proliferation and viability while maintaining the desired cellular characteristics.

Automatically generated - may contain errors

7 protocols using cellgro

1

Generation of Monocyte-Derived Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Leukapheresis was performed using a Cobe Spectra separator (Cobe BCT, Lakewood, CO, USA). All of the following operations were performed under Good Manufacturing Practice (GMP) conditions in the GMP facility of University Hospital Motol using the protocol for DC generation that was approved by the State Institute for Drug Control, as previously described [25 (link), 26 (link)]. The leukapheretic product was diluted in PBS + 1 mM EDTA (Lonza, Verviers, Belgium), and mononuclear cells were separated by Ficoll-Paque Premium (GE Healthcare, Waukesha, WI, USA) gradient centrifugation. Collected mononuclear cells (PBMC) were washed in PBS + 1 mM EDTA (Lonza), resuspended in CellGro medium (CellGenix, Freiburg, Germany) and plated in triple flasks (Thermo Scientific, Waltham, MA, USA) at 1 × 106 cells per cm2 of surface area. After 2 h, non-adherent cells were washed with PBS (Lonza). Adherent monocytes were cultured for 6 days in CellGro (CellGenix) medium with 20 ng/ml of IL-4 (Gentaur, Kampenhout, Belgium) and 500 U/ml of GM-CSF (Gentaur); fresh cytokines were added on day 3. Immature DCs were harvested on day 6, washed in PBS (Lonza) and resuspended in CellGro (CellGenix).
+ Open protocol
+ Expand
2

Autologous APOSEC Production Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood obtained from each study volunteer at the Austrian Red Cross Blood Transfusion Service of Upper Austria was used to produce autologous APOSEC according to current GMP guidelines. PBMCs were separated from whole blood samples of the participants by density centrifugation using LSM 1077 (Lymphocyte Separation Medium, Lonza, Switzerland). Removal of LSM was achieved by two washing steps using Dulbecco’s phosphate-buffered saline (Lonza, Switzerland). PBMCs were resuspended in phenol red–free CellGro GMP DC medium (CellGenix, Freiburg, Germany) containing no xenogeneic proteins. A sample was drawn for complete blood count to adjust white blood cells to a concentration of 25 × 106 cells/ml. Irradiation with 60 Gy induced apoptosis of PBMCs. By cultivation of apoptotic PBMCs in CellGro GMP DC medium, release of the secretome was achieved. After incubation for 24 h ± 2 h, cells were removed by centrifugation. The supernatant containing the secretome was sterile filtered at a pore size of 0.22 μm. The adequate production of APOSEC was defined by appropriate secretion of the following important cytokines: interleukin (IL)-8 (0–5214 pg/ml), epidermal growth factor (EGF; 25–226 pg/ml), and transforming growth factor-β (TGF-β; 2575–21732 pg/ml).
Lyophilized culture medium not containing any cells (CellGro, CellGenix, Freiburg, Germany) served as placebo.
+ Open protocol
+ Expand
3

Isolation and Apoptosis Induction of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMC) were isolated from four healthy male volunteers by venous blood draw and density gradient centrifugation with Ficoll-Paque (GE Healthcare Bio-Sciences AB, Sweden). PBMCs (25 × 106 cells/ml) were resuspended in serum-free medium (CellGro, CellGenix, Freiburg, Germany). An automated cell counter (Sysmex Inc., USA) was used to determine cell count. PBMCs were gamma-irradiated with 60 Gy to induce apoptosis. Induction of apoptosis was confirmed by annexin V-fluorescein/propidium iodide (FITC/PI) co-staining (Becton Dickinson, Franklin Lakes, NJ, USA) using a flow cytometer. At 20h after irradiation 58% of PBMCs were annexin V/PI positive (supplementary Fig. S1). CM was collected from cultures at 2, 4, and 20 h time points, and then, centrifuged (500 × g for 9 min) to remove cell debris. CM was stored at −80 °C for subsequent protein and lipid analyses. Fresh CM was used for microparticle and exosome separations.
+ Open protocol
+ Expand
4

Isolation and Preservation of Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples were maintained in cold saline and brought to the laboratory within 2–4 h of procurement from the donor. Samples were rapidly processed using enzymatic and mechanical digestion to obtain lymphocyte populations with high viability as described in detail (Sathaliyawala et al., 2013 (link); Thome et al., 2014 (link), 2016 (link)). Lymphocytes were isolated from blood using lymphocyte separation media (CellGro; CellGenix) and ACK lysis buffer as previously described (Sathaliyawala et al., 2013 (link)). Lymphocytes were either analyzed immediately or cryopreserved for future analysis.
+ Open protocol
+ Expand
5

Dendritic Cell Generation from Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the generation of dendritic cells (DC) monocytes were obtained through plastic adherence. Briefly, PBMCs were seeded into 75 cm2 flasks for 2 h. Non-adherent cells were removed by extensive washing. The remaining monocytes were incubated in DC medium CellGro (CellGenix, Freiburg, Germany) for 5 days in the presence of 200 IU/ml interleukin (IL)-4 (R&D Systems) and 100 IU/ml granulocyte macrophage colony-stimulating factor (GM-CSF; R&D Systems) to induce an immature DC phenotype. Restimulation with cytokines was performed on days 2 and 5. At day 6 a pool of peptides containing overlapping 20-mer SLLP1 peptides (Peptides&Elephants) at a concentration of 20 µM, respectively, was added to the culture. After 2 h a maturation cocktail was added containing tumor necrosis factor (TNF)-α (5 ng/ml), IL-1β (5 ng/ml), IL-6 (150 ng/ml; all R&D Systems), and prostaglandin (PGE)2 (1 µg/ml; Sigma). The maturation status of the DCs was assessed the next day by flow cytometry using anti-HLA DR, CD80, CD86, CD83, and CD14 monoclonal antibodies (BioLegend, San Diego, CA, USA). Peptide-loaded, mature DCs were either used directly or cryopreserved for later use.
+ Open protocol
+ Expand
6

Cord Blood CD34+ Cell Isolation and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cord blood (CB) samples were collected in sterile tubes containing the anti-coagulant, citrate-dextrose (ACD, Sigma, France) after informed consent and approval was obtained by the institutional review board (Centre international d’infectiologie (CIRI), Lyon, France) according to the Helsinki declaration. Low-density cells were separated over, Ficoll-Hypaque. CD34+ isolation was performed by means of positive selection using magnetic cell separation (Miltenyi MACs) columns according to the manufacturer’s instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). Purity of the selected CD34+ fraction was assessed by FACS analysis with a phycoerythrin (PE)-conjugated anti-CD34 antibody (Miltenyi Biotec, Bergisch Gladbach, Germany) and exceeded 95% for all experiments. Human CD34+ cells were incubated for 18–24 h in 24-well plates in serum-free medium (CellGro, CellGenix, Germany) supplemented with human recombinant: SCF (100 ng/ml), TPO (20 ng/ml), Flt3-L (100 ng/ml) (Myltenyi, France). 5 × 104 prestimulated CD34+ cells were then incubated with nanoblades in 48-well plates in serum-free medium.
+ Open protocol
+ Expand
7

Ex Vivo Expansion of CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mobilized peripheral blood collections were obtained from University Hospital Carl Gustav Carus Dresden. Informed consent was obtained in accordance with a research protocol approved by the local institutional review board. Peripheral blood of healthy donors was collected from leukapheresis products after the donors were treated with 7.5 µg/kg granulocyte colony-stimulating factor for 5 days. CD34 + cells were purified from leukapheresis samples using CD34 antibody-conjugated magnetic beads according to the manufacturer's instructions (Miltenyi Biotec, Frankfurt, Germany). CD34 + cells have a purity of more than 95% as assessed by flow cytometry (fluorescenceactivated cell sorting [FACS]) and a vitality of more than 96% as measured by trypan blue exclusion. CD34 + cells (5 × 10 4 ) were cultured in CellGro (CellGenix, Freiburg, Germany) serum-free medium supplemented with 10 ng/ mL stem cell factor (SCF), 10 ng/mL Fms-related tyrosine kinase 3 ligand (FLT3 ligand), and 10 ng/mL interleukin 3 (IL-3) and incubated at 37 °C in 5% CO 2 . After 24 h, cells were exposed to 1 mM VPA or PBS (control) and incubated for another 7 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!